drugset / Trial / NCT01058902
The Effect Of Aspirin On Survival in Lung Cancer
RandomizedParallel-groupOpen-labelTreatment
Summary
Lung cancer is the most common cancer in the western world. Only 10 to 15 % of patients diagnosed with lung cancer are suitable for potentially curative surgical treatment. Despite surgery, recurrence of lung cancer still occurs. Aspirin potentially may help increase survival by altering the biochemistry of any potential remaining lung cancer cells. Most lung cancer occurs in smokers. Smokers are at increased risk of heart attacks and strokes. Aspirin has beneficial effects on the heart and brain, potentially reducing the incidence of heart attacks and strokes.
Timeline
- Start
- 2010-08
- Primary completion
- 2015-08
- Completion
- 2020-08
Outcome
Outcome not reported
Stopped (Business): “failed to achive funding”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Aspirin | Small molecule | 75 mg | — |